Parion Sciences Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $274K

  • Investors
  • 2

Parion Sciences General Information

Description

Operator of a development-stage company intended to research, develop, and commercialize treatments for diseases with unmet medical needs. The company's technologies target respiratory, ocular, and other epithelial diseases resulting from the patient's ability to protect their mucosal surfaces being compromised, enabling healthcare professionals to restore a patient's innate mucosal defense system.

Contact Information

Website
www.parion.com
Formerly Known As
CyFi
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2800 Meridian Parkway
  • Suite 195
  • Durham, NC 27713
  • United States
+1 (919)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • 2800 Meridian Parkway
  • Suite 195
  • Durham, NC 27713
  • United States
+1 (919)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Parion Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 27-Jan-2020 $274K Completed Clinical Trials - Phase 2
10. Grant 16-Sep-2014 Completed Clinical Trials - Phase 2
9. Grant 01-Jan-2013 Completed Startup
8. Grant 01-Jan-2011 Completed Startup
7. Grant 01-Jan-2010 Completed Startup
6. Grant 01-Jan-2009 Completed Startup
5. Grant 01-Jan-2006 Completed Startup
4. Later Stage VC (Series C) 10-Jan-2005 Completed Startup
3. Grant 01-Jan-2005 $854K $10.1M Completed Startup
2. Early Stage VC (Series B) 07-Jul-2003 $3.57M $10.1M Completed Startup
To view Parion Sciences’s complete valuation and funding history, request access »

Parion Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a development-stage company intended to research, develop, and commercialize treatments for diseases with un
Drug Discovery
Durham, NC
13 As of 2026

Waltham, MA
 

King of Prussia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Parion Sciences Competitors (47)

One of Parion Sciences’s 47 competitors is Visterra, a Venture Capital-Backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Visterra Venture Capital-Backed Waltham, MA
XyloCor Therapeutics Venture Capital-Backed King of Prussia, PA
Centrose Venture Capital-Backed Madison, WI
Tenax Therapeutics Formerly VC-backed Chapel Hill, NC
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
You’re viewing 5 of 47 competitors. Get the full list »

Parion Sciences Patents

  • 462

    Total Documents Applications and Grants

  • Total Patents Families

  • 188

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Parion Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025265075-A1 Methods of clearing mucus from the lungs Pending 21-Jun-2024
US-20250109110-A1 Bicyclic-substituted epithelial sodium channel blocking compounds Pending 26-Jan-2022
WO-2023146896-A1 Bicyclic-substituted epithelial sodium channel blocking compounds Inactive 26-Jan-2022
AU-2023213626-A1 Biphenyl-substituted epithelial sodium channel blocking compounds Pending 26-Jan-2022
EP-4469441-A1 Biphenyl-substituted epithelial sodium channel blocking compounds Pending 26-Jan-2022 C07D241/32
To view Parion Sciences’s complete patent history, request access »

Parion Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Parion Sciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute for Allergy and Infectious Disease Government
National Heart, Lung, and Blood Institute Government
To view Parion Sciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Parion Sciences FAQs

  • When was Parion Sciences founded?

    Parion Sciences was founded in 1999.

  • Where is Parion Sciences headquartered?

    Parion Sciences is headquartered in Durham, NC.

  • What is the size of Parion Sciences?

    Parion Sciences has 13 total employees.

  • What industry is Parion Sciences in?

    Parion Sciences’s primary industry is Drug Discovery.

  • Is Parion Sciences a private or public company?

    Parion Sciences is a Private company.

  • What is Parion Sciences’s current revenue?

    The current revenue for Parion Sciences is .

  • How much funding has Parion Sciences raised over time?

    Parion Sciences has raised $22.1M.

  • Who are Parion Sciences’s investors?

    National Institute for Allergy and Infectious Disease and National Heart, Lung, and Blood Institute have invested in Parion Sciences.

  • Who are Parion Sciences’s competitors?

    Visterra, XyloCor Therapeutics, Centrose, Tenax Therapeutics, and Inovio Pharmaceuticals are some of the 47 competitors of Parion Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process